SCHEMBL4573072

SCHEMBL4573072

COc1nc(N2CCN(C(=O)OC(C)(C)C)C(C)C2)cnc1C1CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP4K4 O95819 2/20 0.51
HDAC1 Q13547 1/20 0.47
GPR119 Q8TDV5 2/20 0.44
PIK3CD O00329 7/20 0.42
SUV39H2 Q9H5I1 2/20 0.41
GRM1 Q13255 2/20 0.40
CKS1B P61024 2/20 0.39
SKP1 P63208 2/20 0.39
SKP2 Q13309 2/20 0.39
CTSB P07858 1/20 0.38
CTSS P25774 1/20 0.38
CTSK P43235 1/20 0.38
PIK3R1 P27986 2/20 0.38
CNR2 P34972 1/20 0.37
PIK3C2B O00750 1/20 0.37
AURKA O14965 1/20 0.37
YES1 P07947 1/20 0.37
HCK P08631 1/20 0.37
FGR P09769 1/20 0.37
EPHA1 P21709 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4573109 1.00 MAP4K4 (0.51) MAP4K4HDAC1GPR119PIK3CDSUV39H2
SCHEMBL4573182 0.86 PIK3CD (0.41) MAP4K4PIK3CDGRM1CTSBCTSS
SCHEMBL4573401 0.86 MAP4K4 (0.52) MAP4K4HDAC1GPR119PIK3CDSUV39H2
SCHEMBL8117739 0.86 MAP4K4 (0.52) MAP4K4HDAC1GPR119PIK3CDSUV39H2
SCHEMBL4573828 0.83 MAP4K4 (0.56) MAP4K4HDAC1GPR119SUV39H2GRM1
SCHEMBL8109939 0.83 MAP4K4 (0.56) MAP4K4HDAC1GPR119SUV39H2GRM1
SCHEMBL4573909 0.82 MAP4K4 (0.46) MAP4K4HDAC1GPR119PIK3CDSUV39H2
SCHEMBL8108577 0.82 MAP4K4 (0.46) MAP4K4HDAC1GPR119PIK3CDSUV39H2
SCHEMBL4573572 0.80 GPR119 (0.51) MAP4K4HDAC1GPR119PIK3CDSUV39H2
SCHEMBL8108991 0.80 GPR119 (0.51) MAP4K4HDAC1GPR119PIK3CDSUV39H2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009001127-A1 CYANOCYCLOPROPYLCARBOXAMIDES AS CATHEPSIN INHIBITORS ASTRAZENECA AB (SE) 2008-12-31 WO disclosed